SSPE Risk and MMR Vaccine Timing

Biological Basis for Age-Dependent SSPE Risk

• Older children (4-6 years) have more mature immune systems and blood-brain barriers, making persistent CNS infection far less likely even with hypothetical vaccine virus exposure 1

MMR Vaccine Timing and Safety Profile

• The first dose of MMR vaccine is recommended at 12-15 months and the second dose at 4-6 years, as per the guidelines from the Centers for Disease Control and Prevention 2, 3, 1
• The American Academy of Pediatrics recommends the MMR vaccination schedule, which supports the age-related biological vulnerability concept, with the primary age-related adverse event being febrile seizures, which are more common after the first dose at 12-47 months 4

Critical Distinction: Vaccine vs Wild-Type Virus

• The Centers for Disease Control and Prevention states that SSPE is caused exclusively by wild-type measles virus, not vaccine strains, and MMR vaccine does not cause SSPE 1

Clinical Implications

• The 12-15 month timing for the first MMR dose is designed to balance maternal antibody waning with the need for early protection against wild-type measles, which does carry SSPE risk, as recommended by the Centers for Disease Control and Prevention 2